Both in Pharmaceuticals
Immix Biopharma vs ArriVent BioPharma
Over the past year IMMX returned +111.8% and AVBP returned −26.0%; their daily moves had a correlation of 0.29.
IMMX +111.8% AVBP −26.0%Growth of $1, one year, split-adjusted
| Metric | IMMX | AVBP |
|---|---|---|
| Price | $7.71 | $13.02 |
| Market cap | $639.2M | $642.0M |
| Today | +6.20% | −2.47% |
| 1 month | −23.9% | −54.3% |
| 6 months | −19.4% | −56.4% |
| Year to date | +47.4% | −35.3% |
| 1 year | +102.9% | −30.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $232.1M | $373.1M |
| Dividend yield | — | — |
| Volatility (60d) | 69.4% | 154.4% |
| Short % of float | 22.5% | 20.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).